Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 2 , Pages 112-119 , June 2008

Photofrin® photodynamic therapy: 2.0mg/kg or not 2.0mg/kg that is the question

References 

  1. Allison RR, Mota HC, Sibata CH. Clinical PD/PDT in North America: an historical review. Photodiag Photodyn Ther. 2004;1(4):263–277
  2. Chopra R, Kondziolka D, Niranjan A, et al. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys. 2007;68(3):845–851
  3. Martin JJ, Niranjan A, Kondziolka D, et al. Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg. 2007;107(4):758–764
  4. Mathieu D, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery. 2007;60(3):460–468[discussion 468–470]
  5. Perez CA, Brady LW, Halperin EC. Perez and Brady's principles and practice of radiation oncology. 5th ed.. Philadelphia: Lippincott Williams & Wilkins; 2008;
  6. Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(4):1124–1129
  7. Wilson BC, Patterson MS, Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci. 1997;12:182–199
  8. Patterson MS, Wilson BC. Photodynamic therapy. In:  Dyh JV editors. The modern technology of radiation oncology. Madison: Medical Physics Publishing; 1999;p. 941–980
  9. Dougherty TJ. Photodynamic therapy. Photochem Photobiol. 1993;58(6):895–900
  10. Mang T. Lasers and light sources for PDT: past, present and future. Photodiag Photodyn Ther. 2004;1(1):43–48
  11. Henderson BW, Dougherty TJ. How does photodynamic therapy work?. Photochem Photobiol. 1992;55(1):145–157
  12. Allison RR, Downie GH, Cuenca R, et al. Photosensitizers in clinical PDT. Photodiag Photodyn Ther. 2004;1(1):27–42
  13. Sibata CH, Colussi VC, Oleinick NL, et al. Photodynamic therapy: a new concept in medical treatment. Braz J Med Biol Res. 2000;33(8):869–880
  14. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889–905
  15. Kessel D, Thompson P, Musselman B, et al. Probing the structure and stability of the tumor-localizing derivative of hematoporphyrin by reductive cleavage with LiAlH4. Cancer Res. 1987;47(17):4642–4645
  16. Rosenkranz AA, Jans DA, Sobolev AS. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol Cell Biol. 2000;78(4):452–464
  17. Fingar VH, Potter WR, Henderson BW. Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changes. Photochem Photobiol. 1987;45(5):643–650
  18. Mang TS, Dougherty TJ, Potter WR, et al. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem Photobiol. 1987;45(4):501–506
  19. Dougherty TJ. Photodynamic therapy: Part II. Semin Surg Oncol. 1995;11(5):333–334
  20. Kato H. Photodynamic therapy for early stage central type of lung cancer. Mayo Clin Proc. 1997;72(7):688–690
  21. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc. 1997;72(7):595–602
  22. Grosjean P, Wagnieres G, Fontolliet C, et al. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514nm compared with 630nm light irradiation after sensitization with Photofrin II. Br J Cancer. 1998;77(11):1989–1995
  23. Overholt BF. Evaluating treatments of Barrett's esophagus that shows high-grade dysplasia. Am J Manag Care. 2000;6(16 Suppl.):S903–S908
  24. Moghissi K, Dixon K. Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?. Eur Respir J. 2003;22(3):535–541
  25. Lightdale CJ. Role of photodynamic therapy in the management of advanced esophageal cancer. Gastrointest Endosc Clin N Am. 2000;10(3):397–408
  26. Jones CM, Mang T, Cooper M, et al. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol. 1992;27(6 Pt 1):979–982
  27. Runfola MA, Weber TK, Rodriguez-Bigas MA, et al. Photodynamic therapy for residual neoplasms of the perianal skin. Dis Colon Rectum. 2000;43(4):499–502
  28. Taber SW, Fingar VH, Wieman TJ. Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J Surg Oncol. 1998;68(4):209–214
  29. Schuh M, Nseyo UO, Potter WR, et al. Photodynamic therapy for palliation of locally recurrent breast carcinoma. J Clin Oncol. 1987;5(11):1766–1770
  30. Khan SA, Dougherty TJ, Mang TS. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur J Cancer. 1993;29A(12):1686–1690
  31. Biel MA. Photodynamic therapy in head and neck cancer. Curr Oncol Rep. 2002;4(1):87–96
  32. Nseyo UO, Lamm DL. Therapy of superficial bladder cancer. Semin Oncol. 1996;23(5):598–604
  33. Moghissi K, Dixon K, Stringer M, et al. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg. 1999;15(1):1–6
  34. Edell ES, Cortese DA, McDougall JC. Ancillary therapies in the management of lung cancer: photodynamic therapy, laser therapy, and endobronchial prosthetic devices. Mayo Clin Proc. 1993;68(7):685–690
  35. Wolfsen HC. Photodynamic therapy in gastroenterology: current status in the year 2000. Endoscopy. 2000;32(9):715–719
  36. Allison RR, Cuenca R, Downie GH, et al. Clinical photodynamic therapy of head and neck cancers—a review of applications and outcomes. Photodiag Photodyn Ther. 2005;2(3):205–222
  37. Allison RR, Sibata CH, Downie GH, et al. A clinical review of PDT for cutaneous malignancies. Photodiag Photodyn Ther. 2006;3(4):214–226
  38. Khan SADT, Mang TS. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Br J Cancer. 1993;29A:1686–1690
  39. Nseyo UO, Shumaker B, Klein EA, et al. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. J Urol. 1998;160(1):39–44
  40. Kriegmair M, Waidelich R, Lumper W, et al. Integral photodynamic treatment of refractory superficial bladder cancer. J Urol. 1995;154(4):1339–1341
  41. Wilson BD, Mang TS, Stoll H, et al. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol. 1992;128(12):1597–1601
  42. McCaughan JS, Guy JT, Hawley P, et al. Hematoporphyrin-derivative and photoradiation therapy of malignant tumors. Lasers Surg Med. 1983;3(3):199–209
  43. Baert L, Berg R, Van Damme B, et al. Clinical fluorescence diagnosis of human bladder carcinoma following low-dose Photofrin injection. Urology. 1993;41(4):322–330
  44. Allison RR, Mota HC, Bagnato VS, et al. Bio-nanotechnology and photodynamic therapy—state of art review. Photodiag Photodyn Ther. 2008;5:19–28
  45. Oseroff AR, Blumenson LR, Wilson BD, et al. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma. Lasers Surg Med. 2006;38(5):417–426
  46. Henderson BW, Busch TM, Vaughan LA, et al. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res. 2000;60(3):525–529
  47. Fingar VH, Henderson BW. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem Photobiol. 1987;46(5):837–841
  48. Buchanan RB, Carruth JA, McKenzie AL, et al. Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur J Surg Oncol. 1989;15(5):400–406
  49. Robinson PJ, Carruth JA, Fairris GM. Photodynamic therapy: a better treatment for widespread Bowen's disease. Br J Dermatol. 1988;119(1):59–61
  50. Wilson BD, Mang TS, Cooper M, et al. Use of photodynamic therapy for the treatment of extensive basal cell carcinomas. Facial Plast Surg. 1989;6(3):185–189
  51. Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol. 2003;39(17–18):1133–1136
  52. Oseroff A. PDT as a cytotoxic agent and biological response modifier: implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J Invest Dermatol. 2006;126(3):542–544
  53. Allison RR, Mang TS, Wilson BD. Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin Cutan Med Surg. 1998;17(2):153–163
  54. Allison R, Mang T, Hewson G, et al. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer. 2001;91(1):1–8
  55. Cuenca RE, Allison RR, Sibata C, et al. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol. 2004;11(3):322–327
  56. Sperduto PW, DeLaney TF, Thomas G, et al. Photodynamic therapy for chest wall recurrence in breast cancer. Int J Radiat Oncol Biol Phys. 1991;21(2):441–446
  57. Bernstein ZP, Wilson BD, Oseroff AR, et al. Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma. AIDS. 1999;13(13):1697–1704

PII: S1572-1000(08)00044-6

doi: 10.1016/j.pdpdt.2008.05.004

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 2 , Pages 112-119 , June 2008

Article Tools

* Image Usage & Resolution